Establishment of a PDT Patient Registry

Lung Cancer Clinical Trial

Official title: Establishment of a Registry for Patients Treated With Photodynamic Therapy (PDT)

Status Terminated

Clinical Trial Summary

This is a non-intervention patient registry to gather data on the use of photodynamic therapy under real-life conditions. It will involve up to 20 sites in USA.

Clinical Trial Description

The purpose of this patient registry is to collect information about a patient's cancer treatment, photodynamic therapy (PDT), used alone or in combination with surgery, chemotherapy and radiotherapy. Patients will be registered either before or after PDT is performed, regardless of the indication. Analysis of this information may help to refine the treatment care. Data collected in the registry includes patient characteristics/demographics, disease characteristics, treatment details (photodynamic therapy, radiation, chemotherapy, surgery, etc.), side effects, and survival outcomes. By participating in this registry, patients will not be asked to do anything that would not ordinarily be done as a matter of routine care including clinical assessments, laboratory tests, radiology procedures, and treatments. Information on disease, condition, and treatment will be recorded in the registry during routine visits. ;

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

• NCT number: NCT03589456
• Study type: Observational [Patient Registry]
• Source: Concordia Laboratories Inc.
• Status: Terminated
• Start date: January 18, 2019
• Completion date: January 15, 2020